Quote:
Originally Posted by mrsD
One would think Big Pharma could provide the needed evidence by now about mechanisms of action?
|
One would think so - but gabapentin is now available generically and is not very expensive. So, there is not much incentive for the pharmaceutical companies to put money into complex studies.
If someone had exclusive license, and could sell gabapentin for $1000/month - we would know a lot more in short order.